Degarelix vs standard androgen suppression therapy
Quality of life · hormone‐sensitive prostate cancer
1 finding from 1 review
- Degarelix for treating advanced hormone‐sensitive prostate cancer 2021 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 2887 participantsModerate